Superior Cell Delivery Features of Poly(ethylene glycol) Incorporated Alginate, Chitosan, and Poly-l-lysine Microcapsules
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Microencapsulation is an emerging technology in the development of bioartificial organs for drug, protein, and delivery systems. One of the advancements in establishing an appropriate membrane material for live cell and tissue encapsulation is the incorporation of poly(ethylene glycol) (PEG) to the widely studied alginate microcapsules. The current study investigates the properties of integrating PEG to microcapsules coated with poly-L-lysine (PLL) and chitosan as well as a novel microcapsule membrane which combines both PLL and chitosan. Results show that microcapsules containing PEG can support cell viability and protein secretion. The addition of PEG to PLL and chitosan-coated microcapsules improves the stability of microcapsules when exposed to a hypotonic solution. We also compared the novel microcapsule with two other previously used microcapsules including alginate-chitosan-PEG and alginate-PLL-PEG-alginate. Results show that all three membranes are capable of providing immunoprotection to the cells and have the potential for long-term storage at -80 degrees C. The novel membrane containing PEG, chitosan, and PLL, however, revealed the highest cell viability and mechanical strength when exposed to external rotational force, but it was unable to sustain osmotic pressure. The study revealed the potential of using PEG-incorporated alginate, chitosan, and PLL microcapsules for encapsulating live cells producing proteins and hormones for therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microencapsulated human hepatoma (HepG2) cells: In vitro growth and protein release
Uludag, H., & Sefton, M. V. (1993) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820271002 · Cited by 74
Cited by
Antimicrobial properties of chitosan and mode of action: a state of the art review
Kong, M., Chen, X. G., Xing, K., & Park, H. J. (2010) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2010.09.012 · Cited by 3,037
Antimicrobial Actions and Applications of Chitosan
Ke, C.-L., Deng, F.-S., Chuang, C.-Y., & Lin, C.-H. (2021) · Polymers · doi:10.3390/polym13060904 · Cited by 949
Microparticles, Microspheres, and Microcapsules for Advanced Drug Delivery
Lengyel, M., Kállai-Szabó, N., Antal, V., Laki, A. J., & Antal, I. (2019) · Scientia Pharmaceutica · doi:10.3390/scipharm87030020 · Cited by 598
Chitooligosaccharide and Its Derivatives: Preparation and Biological Applications
Lodhi, G., Kim, Y.-S., Hwang, J.-W., Kim, S.-K., Jeon, Y.-J., Je, J.-Y., Ahn, C.-B., Moon, S.-H., Jeon, B.-T., & Park, P.-J. (2014) · BioMed Research International · doi:10.1155/2014/654913 · Cited by 358
Tikhonov, V. E., Stepnova, E. A., Babak, V. G., Yamskov, I. A., Palma-Guerrero, J., Jansson, H.-B., Lopez-Llorca, L. V., Salinas, J., Gerasimenko, D. V., Avdienko, I. D., et al. (2006) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2005.10.021 · Cited by 345
Varma, R., & Vasudevan, S. (2020) · ACS Omega · doi:10.1021/acsomega.0c01903 · Cited by 310
Shih, P.-Y., Liao, Y.-T., Tseng, Y.-K., Deng, F.-S., & Lin, C.-H. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00602 · Cited by 156
“Furthermore, chitosan has been reported to have broad-spectrum antimicrobial activity against Gram-positive bacteria, Gram-negative bacteria and fungi (Kendra and Hadwiger, 1984; Hirano and Nagao, 1989; Tikhonov et al., 2006; Pena et al., 2013; Cheung et al., 2015).”
BackgroundKe, C.-L., Liao, Y.-T., & Lin, C.-H. (2021) · Virulence · doi:10.1080/21505594.2020.1870082 · Cited by 41
Metadata
- Authors
- Haque, T., Chen, H., Ouyang, W., Martoni, C., Lawuyi, B., Urbanska, A. M., & Prakash, S.
- Venue
- Molecular Pharmaceutics
- Publisher
- American Chemical Society (ACS)
- Published
- 2004-12-24
- Volume
- 2
- Issue
- 1
- Pages
- 29-36
- ISSN
- 1543-8384 (ISSN-L)
- 1543-8392
- OpenAlex
- W1992046126
- Cited by
- 79
- References
- 1
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.